Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk.

Journal

Nature cardiovascular research
ISSN: 2731-0590
Titre abrégé: Nat Cardiovasc Res
Pays: England
ID NLM: 9918284280206676

Informations de publication

Date de publication:
Apr 2024
Historique:
medline: 7 6 2024
pubmed: 7 6 2024
entrez: 7 6 2024
Statut: ppublish

Résumé

Cardiovascular disease (CVD) is the leading cause of death among people with type 2 diabetes

Identifiants

DOI: 10.1038/s44161-024-00453-9 PMID: 38846711 PMC: PMC11156225
pubmed: 38846711
doi: 10.1038/s44161-024-00453-9
pmc: PMC11156225
doi:

Banques de données

ClinicalTrials.gov
['NCT05214573']

Types de publication

Journal Article

Langues

eng

Pagination

431-440

Auteurs

Rozalina G McCoy (RG)

Division of Endocrinology, Diabetes, & Nutrition, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
University of Maryland Institute for Health Computing, Bethesda, MD, USA.
Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.
OptumLabs, Eden Prairie, MN, USA.
ORCID: 0000-0002-2289-3183

Jeph Herrin (J)

Section of Cardiovascular Medicine, Yale School of Medicine, New Haven, CT, USA.

Kavya Sindhu Swarna (KS)

OptumLabs, Eden Prairie, MN, USA.
Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, MN, USA.

Yihong Deng (Y)

OptumLabs, Eden Prairie, MN, USA.
Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, MN, USA.

David M Kent (DM)

Predictive Analytics and Comparative Effectiveness (PACE) Center, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.

Joseph S Ross (JS)

Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA.
ORCID: 0000-0002-9218-3320

Guillermo E Umpierrez (GE)

Division of Endocrinology, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
ORCID: 0000-0002-3252-5026

Rodolfo J Galindo (RJ)

Division of Endocrinology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.

William H Crown (WH)

Florence Heller Graduate School, Brandeis University, Waltham, MA, USA.

Bijan J Borah (BJ)

Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, MN, USA.

Victor M Montori (VM)

Division of Endocrinology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, MN, USA.

Juan P Brito (JP)

Division of Endocrinology, Department of Medicine, Mayo Clinic, Rochester, MN, USA.
Knowledge and Evaluation Research Unit, Mayo Clinic, Rochester, MN, USA.

Joshua J Neumiller (JJ)

Department of Pharmacotherapy, Washington State University, Spokane, WA, USA.
Providence Medical Research Center, Spokane, WA, USA.

Mindy M Mickelson (MM)

Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Rochester, MN, USA.

Eric C Polley (EC)

Department of Public Health Sciences, University of Chicago, Chicago, IL, USA.

Classifications MeSH